![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
HELLP syndrome with reversible posterior leukoencephalopathy
We report the case of a 30-year-old primipara who developed a triplet pregnancy after having received artificial insemination. At the end of the eighth month of pregnancy she had a generalized tonic-clonic se...
-
Article
Epileptic seizures in multiple sclerosis: clinical and EEG correlations
Epileptic seizures occur more frequently in multiple sclerosis (MS) patients than in the general population. We evaluated clinical, electroencephalographic (EEG) and magnetic resonance imaging (MRI) findings, ...
-
Article
RETRACTED ARTICLE: The pattern of c-Fos immunoreactivity in the hindbrain of the rat following stomach distension
It has been previously shown that the walls of the stomach contain vagal and splanchnic afferents, connected to low and high threshold (LT and HT) gastric receptors, that convey physiological and noxious infor...
-
Article
A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis
Despite clinical similitude, there is a tendency to consider trigeminal pain in multiple sclerosis (MS) as a distinct condition. To evaluate clinical differences in trigeminal pain presentation in patients wit...
-
Article
Levetiracetam for cerebellar tremor in multiple sclerosis
Disabling tremor is frequent in multiple sclerosis (MS) and its treatment remains challenging. We conducted an open–label trial to evaluate the effect of levetiracetam (LEV) to treat cerebellar tremor in MS pa...
-
Article
Multiple sclerosis and headache co-morbidity. A case-control study
The prevalence of primary headache (PH) in a multiple sclerosis (MS) sample vs. control healthy subjects was investigated at a neurological clinic in 2004–2005: 122 of 238 (51%) MS patients and 57 of 238 (23%) co...
-
Article
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy
The identification of predictive factors of NAbs development might have a relevant impact on clinical practice. Our objective is to look after predictive factors of NAbs development in MS IFN Beta-1b-treated p...
-
Article
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice
Natalizumab is one option for multiple sclerosis patients responding poorly to classical immunomodulators, but pilot studies did not point to its effectiveness as a second-line therapy. Aim of this study was t...
-
Article
Idiopathic intracranial hypertension in a patient with thyroid papillary carcinoma
-
Article
Retraction Note: The pattern of c-Fos immunoreactivity in the hindbrain of the rat following stomach distension